2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung CancerNon-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorActive, not recruitingPhase 22026-09-01NCT04619004
Sentinel Node Vs Observation After Axillary Ultra-souNDEarly Stage Breast CarcinomaActive, not recruitingNot applicable2024-11-25NCT02167490